One group examined the effects of cetuximab and erlotinib on stem cell sub-populations in HNSCC cell lines, and found that these EGFR inhibitors induced large shifts of cells between the epithelial and mesenchymal cancer stem cell populations [35]. The gene discussed is EGFR; the disease is cancer.